Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:34 PM
Ignite Modification Date:
2025-12-24 @ 9:34 PM
NCT ID:
NCT03695432
Eligibility Criteria:
Inclusion Criteria:
* all health elderly aged ≥ 60 years
* who came to the vaccination and health education activities in the entire East Jakarta District Health Center
* with Body Mass Index (BMI) 17,5-29,9
* healthy mental status (MMSE score of 28-30)
Exclusion Criteria:
* subject who have contraindications to influenza vaccinations
* are undergoing treatment related to immune system modulation in the past 4 weeks
* therapy for immunossuppresants and/ or corticosteroids eqivalent to prednisone ≥ 20 mg/day that is being lived more than 2 weeks or has only been stopped less than 3 months before the study
* recieved influenza vaccination less than one year before
* Currently consuming probiotic agents, either in the form of a manufacturer or natural for more than 7 days.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
60 Years
Maximum Age:
90 Years
Study:
NCT03695432
Study Brief:
Protocol Section:
NCT03695432